Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 127 | 2025 | 3788 | 21.120 |
Why?
|
Rheumatic Diseases | 47 | 2025 | 658 | 9.170 |
Why?
|
Lung Diseases, Interstitial | 32 | 2024 | 939 | 8.980 |
Why?
|
Antirheumatic Agents | 44 | 2025 | 1383 | 8.230 |
Why?
|
Rheumatology | 23 | 2024 | 619 | 4.320 |
Why?
|
Autoimmune Diseases | 17 | 2025 | 2254 | 2.620 |
Why?
|
Smoking | 25 | 2024 | 9077 | 2.540 |
Why?
|
Methotrexate | 15 | 2025 | 1719 | 2.220 |
Why?
|
Bronchiectasis | 3 | 2024 | 141 | 2.200 |
Why?
|
Lupus Erythematosus, Systemic | 22 | 2024 | 2160 | 1.760 |
Why?
|
Hydroxychloroquine | 11 | 2021 | 427 | 1.750 |
Why?
|
Rheumatoid Factor | 8 | 2023 | 185 | 1.750 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 9 | 2024 | 3246 | 1.710 |
Why?
|
Arthritis, Psoriatic | 5 | 2023 | 219 | 1.520 |
Why?
|
Risk Factors | 81 | 2025 | 74881 | 1.330 |
Why?
|
Nurses | 17 | 2024 | 2503 | 1.300 |
Why?
|
Biological Products | 8 | 2024 | 948 | 1.210 |
Why?
|
Autoantibodies | 14 | 2024 | 2115 | 1.140 |
Why?
|
Women's Health | 4 | 2021 | 2081 | 1.120 |
Why?
|
Sarcoidosis | 3 | 2019 | 535 | 1.120 |
Why?
|
Humans | 242 | 2025 | 766766 | 1.110 |
Why?
|
Health Behavior | 5 | 2022 | 2649 | 1.100 |
Why?
|
Tobacco Smoke Pollution | 3 | 2021 | 828 | 1.050 |
Why?
|
Middle Aged | 119 | 2025 | 223257 | 1.050 |
Why?
|
Asthma | 8 | 2023 | 6268 | 1.050 |
Why?
|
Autoimmunity | 4 | 2024 | 1358 | 1.040 |
Why?
|
Arthritis | 3 | 2024 | 684 | 0.980 |
Why?
|
Risk Reduction Behavior | 4 | 2021 | 1120 | 0.970 |
Why?
|
Air Pollution | 3 | 2024 | 2391 | 0.930 |
Why?
|
Lung Transplantation | 2 | 2024 | 1310 | 0.920 |
Why?
|
Incidence | 33 | 2024 | 21525 | 0.920 |
Why?
|
Sinusitis | 3 | 2024 | 997 | 0.920 |
Why?
|
Female | 139 | 2025 | 396520 | 0.920 |
Why?
|
Glucocorticoids | 12 | 2024 | 2158 | 0.900 |
Why?
|
Disease Progression | 13 | 2024 | 13640 | 0.890 |
Why?
|
Case-Control Studies | 27 | 2024 | 22248 | 0.890 |
Why?
|
Spirometry | 2 | 2024 | 929 | 0.870 |
Why?
|
Bone Diseases | 2 | 2019 | 412 | 0.850 |
Why?
|
Prospective Studies | 47 | 2025 | 54871 | 0.850 |
Why?
|
Gout | 4 | 2022 | 622 | 0.780 |
Why?
|
Adult | 89 | 2025 | 223307 | 0.760 |
Why?
|
Male | 98 | 2025 | 364142 | 0.740 |
Why?
|
Antigens, Viral | 1 | 2024 | 995 | 0.700 |
Why?
|
Patient Education as Topic | 4 | 2019 | 2334 | 0.690 |
Why?
|
Smoking Cessation | 4 | 2019 | 2085 | 0.660 |
Why?
|
Psoriasis | 3 | 2023 | 925 | 0.660 |
Why?
|
Risk Assessment | 25 | 2025 | 24295 | 0.660 |
Why?
|
Air Pollutants | 3 | 2024 | 2931 | 0.650 |
Why?
|
Antimalarials | 3 | 2020 | 909 | 0.640 |
Why?
|
Aged | 59 | 2025 | 171343 | 0.640 |
Why?
|
Pulmonary Emphysema | 1 | 2024 | 683 | 0.640 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2019 | 45 | 0.630 |
Why?
|
Early Diagnosis | 1 | 2024 | 1186 | 0.630 |
Why?
|
Mucin-5B | 4 | 2023 | 148 | 0.620 |
Why?
|
Climate Change | 1 | 2024 | 509 | 0.580 |
Why?
|
Life Style | 6 | 2022 | 3926 | 0.570 |
Why?
|
Gastrointestinal Agents | 1 | 2021 | 511 | 0.550 |
Why?
|
Environmental Exposure | 5 | 2024 | 4554 | 0.540 |
Why?
|
Pneumonia | 2 | 2020 | 2159 | 0.540 |
Why?
|
Antiviral Agents | 4 | 2024 | 3070 | 0.530 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2018 | 187 | 0.530 |
Why?
|
Public Opinion | 1 | 2020 | 484 | 0.530 |
Why?
|
Peptides, Cyclic | 4 | 2022 | 390 | 0.530 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 437 | 0.530 |
Why?
|
Sulfasalazine | 1 | 2016 | 85 | 0.520 |
Why?
|
Coronavirus Infections | 8 | 2021 | 3110 | 0.520 |
Why?
|
Immunosuppressive Agents | 4 | 2022 | 4215 | 0.510 |
Why?
|
Lung | 11 | 2024 | 10067 | 0.510 |
Why?
|
Drug Monitoring | 1 | 2021 | 962 | 0.500 |
Why?
|
Seafood | 1 | 2019 | 395 | 0.500 |
Why?
|
Fusarium | 1 | 2015 | 50 | 0.500 |
Why?
|
Diet | 7 | 2024 | 8088 | 0.490 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2018 | 4056 | 0.490 |
Why?
|
Gastritis | 1 | 2017 | 199 | 0.490 |
Why?
|
Sex Factors | 9 | 2025 | 10619 | 0.490 |
Why?
|
Bariatric Surgery | 3 | 2020 | 996 | 0.490 |
Why?
|
Health Education | 2 | 2018 | 1060 | 0.480 |
Why?
|
Granuloma | 1 | 2017 | 329 | 0.480 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 358 | 0.460 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3232 | 0.460 |
Why?
|
Family | 2 | 2016 | 3209 | 0.460 |
Why?
|
Registries | 11 | 2023 | 8351 | 0.460 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1794 | 0.420 |
Why?
|
Antibodies, Antinuclear | 5 | 2024 | 340 | 0.420 |
Why?
|
Vital Capacity | 3 | 2024 | 995 | 0.420 |
Why?
|
United States | 33 | 2025 | 72951 | 0.390 |
Why?
|
Time Factors | 18 | 2024 | 40149 | 0.390 |
Why?
|
Vaccination | 12 | 2024 | 3434 | 0.390 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15657 | 0.390 |
Why?
|
Myositis | 3 | 2024 | 268 | 0.380 |
Why?
|
Arthritis, Infectious | 1 | 2015 | 347 | 0.380 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12534 | 0.380 |
Why?
|
Retrospective Studies | 19 | 2025 | 81635 | 0.370 |
Why?
|
Cohort Studies | 23 | 2025 | 41710 | 0.370 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1463 | 0.370 |
Why?
|
Respiratory Function Tests | 5 | 2024 | 1691 | 0.360 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 18075 | 0.340 |
Why?
|
Severity of Illness Index | 7 | 2022 | 15908 | 0.330 |
Why?
|
Logistic Models | 9 | 2022 | 13278 | 0.320 |
Why?
|
Exercise | 4 | 2022 | 5945 | 0.320 |
Why?
|
Lung Diseases | 1 | 2019 | 1941 | 0.320 |
Why?
|
Connective Tissue Diseases | 3 | 2024 | 285 | 0.320 |
Why?
|
Obesity | 6 | 2020 | 13090 | 0.310 |
Why?
|
Environment | 1 | 2014 | 1120 | 0.300 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2018 | 1399 | 0.300 |
Why?
|
Physicians | 2 | 2023 | 4591 | 0.290 |
Why?
|
Serologic Tests | 2 | 2021 | 382 | 0.290 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2019 | 64 | 0.290 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9244 | 0.290 |
Why?
|
Prednisone | 5 | 2023 | 1566 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2306 | 0.280 |
Why?
|
Body Weight | 1 | 2017 | 4626 | 0.270 |
Why?
|
Musculoskeletal Diseases | 2 | 2023 | 598 | 0.270 |
Why?
|
Neoplasms | 5 | 2024 | 22350 | 0.270 |
Why?
|
Body Mass Index | 9 | 2021 | 13050 | 0.260 |
Why?
|
Immunologic Factors | 3 | 2024 | 1594 | 0.260 |
Why?
|
Prevalence | 6 | 2023 | 15835 | 0.260 |
Why?
|
Inflammation | 6 | 2024 | 10860 | 0.250 |
Why?
|
Pandemics | 10 | 2023 | 8735 | 0.250 |
Why?
|
Hospitalization | 9 | 2025 | 10823 | 0.250 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13485 | 0.240 |
Why?
|
Risk | 4 | 2021 | 9602 | 0.240 |
Why?
|
Double-Blind Method | 6 | 2021 | 12430 | 0.230 |
Why?
|
Scleroderma, Systemic | 3 | 2024 | 346 | 0.230 |
Why?
|
Research Design | 4 | 2022 | 6207 | 0.230 |
Why?
|
Remission Induction | 3 | 2021 | 2413 | 0.220 |
Why?
|
Bone and Bones | 1 | 2014 | 2559 | 0.220 |
Why?
|
Antibodies, Viral | 6 | 2024 | 3212 | 0.220 |
Why?
|
Age Factors | 7 | 2020 | 18397 | 0.210 |
Why?
|
I-kappa B Kinase | 1 | 2024 | 250 | 0.210 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 232 | 0.210 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1852 | 0.210 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 231 | 0.210 |
Why?
|
Odds Ratio | 6 | 2022 | 9661 | 0.200 |
Why?
|
Folic Acid | 2 | 2021 | 1337 | 0.200 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 154 | 0.200 |
Why?
|
Influenza, Human | 1 | 2013 | 1543 | 0.200 |
Why?
|
Forced Expiratory Volume | 2 | 2024 | 1828 | 0.200 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2023 | 125 | 0.190 |
Why?
|
Alanine | 1 | 2024 | 613 | 0.190 |
Why?
|
Receptors, Interleukin-6 | 1 | 2023 | 227 | 0.190 |
Why?
|
Oral Health | 2 | 2019 | 493 | 0.190 |
Why?
|
Comorbidity | 8 | 2024 | 10580 | 0.180 |
Why?
|
Depression | 1 | 2021 | 8228 | 0.180 |
Why?
|
Lymphoma, T-Cell | 1 | 2023 | 308 | 0.180 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5789 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2270 | 0.180 |
Why?
|
Myasthenia Gravis | 1 | 2023 | 214 | 0.180 |
Why?
|
Interleukin-12 | 1 | 2023 | 581 | 0.170 |
Why?
|
Alcohol Drinking | 3 | 2020 | 4045 | 0.170 |
Why?
|
Emphysema | 1 | 2022 | 234 | 0.170 |
Why?
|
Treatment Outcome | 9 | 2023 | 65273 | 0.170 |
Why?
|
Thorax | 1 | 2022 | 555 | 0.160 |
Why?
|
Premature Birth | 2 | 2023 | 1830 | 0.160 |
Why?
|
Drug Resistance, Viral | 1 | 2024 | 868 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 620 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2023 | 608 | 0.160 |
Why?
|
Postmenopause | 2 | 2018 | 2517 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2022 | 553 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 166 | 0.160 |
Why?
|
Health Surveys | 3 | 2019 | 4055 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 16044 | 0.150 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4278 | 0.150 |
Why?
|
Immunocompromised Host | 2 | 2020 | 865 | 0.150 |
Why?
|
Nutritive Value | 1 | 2021 | 351 | 0.150 |
Why?
|
Area Under Curve | 3 | 2021 | 1638 | 0.150 |
Why?
|
Diet Surveys | 2 | 2021 | 1159 | 0.150 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1733 | 0.150 |
Why?
|
Granzymes | 1 | 2019 | 278 | 0.150 |
Why?
|
Aged, 80 and over | 10 | 2022 | 59550 | 0.150 |
Why?
|
Steroids | 1 | 2023 | 936 | 0.150 |
Why?
|
Lung Injury | 1 | 2022 | 432 | 0.150 |
Why?
|
Multivariate Analysis | 6 | 2020 | 12064 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12985 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 520 | 0.140 |
Why?
|
Occupational Therapy | 1 | 2019 | 140 | 0.140 |
Why?
|
Respiration, Artificial | 4 | 2022 | 2727 | 0.140 |
Why?
|
Mass Media | 1 | 2020 | 302 | 0.140 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39309 | 0.140 |
Why?
|
Demography | 1 | 2022 | 1641 | 0.140 |
Why?
|
Obesity, Abdominal | 1 | 2020 | 371 | 0.140 |
Why?
|
Medical History Taking | 1 | 2021 | 779 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2023 | 6307 | 0.140 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12806 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 596 | 0.140 |
Why?
|
Sweden | 1 | 2020 | 1382 | 0.140 |
Why?
|
Interinstitutional Relations | 1 | 2018 | 235 | 0.140 |
Why?
|
Citrulline | 1 | 2016 | 106 | 0.130 |
Why?
|
Military Medicine | 1 | 2018 | 185 | 0.130 |
Why?
|
Metabolome | 2 | 2020 | 1009 | 0.130 |
Why?
|
Life Change Events | 1 | 2021 | 956 | 0.130 |
Why?
|
Cyclooxygenase 2 | 1 | 2018 | 596 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2022 | 848 | 0.130 |
Why?
|
Chemokines | 1 | 2020 | 962 | 0.130 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 787 | 0.130 |
Why?
|
Epidemiologic Studies | 1 | 2019 | 677 | 0.130 |
Why?
|
Myocarditis | 1 | 2023 | 802 | 0.130 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2534 | 0.130 |
Why?
|
Phosphoproteins | 1 | 2024 | 2448 | 0.120 |
Why?
|
Rheumatic Fever | 1 | 2015 | 73 | 0.120 |
Why?
|
Osteonecrosis | 1 | 2017 | 230 | 0.120 |
Why?
|
Communication | 2 | 2020 | 3905 | 0.120 |
Why?
|
Needs Assessment | 2 | 2019 | 1140 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 533 | 0.120 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2018 | 304 | 0.120 |
Why?
|
Prognosis | 3 | 2021 | 29948 | 0.120 |
Why?
|
HLA Antigens | 1 | 2020 | 1339 | 0.120 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 550 | 0.120 |
Why?
|
Arginine | 1 | 2018 | 932 | 0.120 |
Why?
|
Publishing | 1 | 2022 | 837 | 0.120 |
Why?
|
Military Personnel | 2 | 2021 | 1260 | 0.120 |
Why?
|
Complementary Therapies | 1 | 2019 | 486 | 0.120 |
Why?
|
Electronic Health Records | 2 | 2024 | 4880 | 0.120 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 66 | 0.120 |
Why?
|
Genes, MHC Class II | 1 | 2015 | 433 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 893 | 0.120 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 454 | 0.120 |
Why?
|
Algorithms | 3 | 2020 | 14072 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 681 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2017 | 602 | 0.110 |
Why?
|
Hematinics | 1 | 2017 | 282 | 0.110 |
Why?
|
Vomiting | 1 | 2017 | 652 | 0.110 |
Why?
|
Amino Acids | 2 | 2021 | 1711 | 0.110 |
Why?
|
Biomedical Research | 2 | 2020 | 3459 | 0.110 |
Why?
|
Carotenoids | 1 | 2017 | 620 | 0.110 |
Why?
|
Epitopes | 2 | 2017 | 2526 | 0.110 |
Why?
|
Young Adult | 10 | 2024 | 59939 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14762 | 0.110 |
Why?
|
Fibrosis | 1 | 2021 | 2077 | 0.110 |
Why?
|
Endosonography | 1 | 2017 | 626 | 0.110 |
Why?
|
Aminolevulinic Acid | 1 | 2014 | 147 | 0.110 |
Why?
|
Carbonated Beverages | 1 | 2014 | 209 | 0.100 |
Why?
|
Hormone Replacement Therapy | 1 | 2018 | 751 | 0.100 |
Why?
|
Overweight | 2 | 2014 | 2446 | 0.100 |
Why?
|
Research Personnel | 1 | 2018 | 589 | 0.100 |
Why?
|
Spondylitis, Ankylosing | 1 | 2014 | 158 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2232 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4652 | 0.100 |
Why?
|
Antibody Formation | 3 | 2023 | 1392 | 0.100 |
Why?
|
Physical Examination | 1 | 2019 | 1265 | 0.100 |
Why?
|
Particulate Matter | 1 | 2024 | 2635 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2014 | 241 | 0.100 |
Why?
|
Mentors | 1 | 2018 | 671 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20708 | 0.100 |
Why?
|
Immunity, Innate | 1 | 2024 | 3077 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 684 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4142 | 0.100 |
Why?
|
Rare Diseases | 1 | 2017 | 630 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3342 | 0.090 |
Why?
|
Information Dissemination | 1 | 2020 | 1142 | 0.090 |
Why?
|
Weight Gain | 2 | 2022 | 2356 | 0.090 |
Why?
|
Cytokines | 3 | 2022 | 7438 | 0.090 |
Why?
|
Gastrectomy | 1 | 2015 | 693 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 744 | 0.090 |
Why?
|
Alleles | 4 | 2024 | 6895 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 1 | 2020 | 2258 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3716 | 0.090 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26310 | 0.080 |
Why?
|
Hypersensitivity | 1 | 2019 | 1169 | 0.080 |
Why?
|
Health Communication | 1 | 2013 | 216 | 0.080 |
Why?
|
China | 3 | 2020 | 2383 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1156 | 0.080 |
Why?
|
Menopause | 1 | 2017 | 1657 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1101 | 0.080 |
Why?
|
Immunophenotyping | 2 | 2024 | 1867 | 0.080 |
Why?
|
Lower Extremity | 1 | 2017 | 1217 | 0.080 |
Why?
|
Chloroquine | 2 | 2020 | 276 | 0.080 |
Why?
|
Kidney | 2 | 2021 | 7074 | 0.080 |
Why?
|
Azithromycin | 2 | 2020 | 201 | 0.080 |
Why?
|
Coronary Artery Disease | 2 | 2018 | 6558 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2021 | 2903 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2025 | 8045 | 0.080 |
Why?
|
Phenotype | 3 | 2017 | 16724 | 0.070 |
Why?
|
Survival Analysis | 2 | 2017 | 10100 | 0.070 |
Why?
|
Motivation | 1 | 2018 | 2020 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6512 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2024 | 11920 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2018 | 3853 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2823 | 0.070 |
Why?
|
Patient Care Team | 1 | 2019 | 2519 | 0.070 |
Why?
|
Disease | 1 | 2013 | 675 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2015 | 820 | 0.070 |
Why?
|
Societies, Medical | 3 | 2024 | 3957 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1889 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2429 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8507 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10264 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2520 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2019 | 3618 | 0.060 |
Why?
|
Genetic Variation | 2 | 2024 | 6612 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2418 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1904 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5387 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18330 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1805 | 0.060 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2024 | 32 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5700 | 0.060 |
Why?
|
International Classification of Diseases | 2 | 2023 | 935 | 0.060 |
Why?
|
Adolescent | 7 | 2024 | 88904 | 0.060 |
Why?
|
Weight Loss | 1 | 2015 | 2712 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2039 | 0.060 |
Why?
|
Food Handling | 1 | 2024 | 158 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2014 | 7841 | 0.050 |
Why?
|
Child | 4 | 2023 | 80668 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7475 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9346 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3420 | 0.050 |
Why?
|
Endemic Diseases | 1 | 2023 | 190 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6779 | 0.050 |
Why?
|
Sjogren's Syndrome | 1 | 2024 | 240 | 0.050 |
Why?
|
Ireland | 1 | 2022 | 171 | 0.050 |
Why?
|
Fast Foods | 1 | 2024 | 220 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3837 | 0.050 |
Why?
|
Models, Structural | 1 | 2022 | 339 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 331 | 0.050 |
Why?
|
Prednisolone | 1 | 2022 | 326 | 0.050 |
Why?
|
B-Cell Activating Factor | 1 | 2021 | 116 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2023 | 391 | 0.050 |
Why?
|
Fabaceae | 1 | 2021 | 103 | 0.050 |
Why?
|
Putrescine | 1 | 2020 | 42 | 0.050 |
Why?
|
Xenobiotics | 1 | 2021 | 71 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4784 | 0.050 |
Why?
|
Butyric Acid | 1 | 2020 | 51 | 0.050 |
Why?
|
Spermidine | 1 | 2020 | 63 | 0.050 |
Why?
|
Databases, Factual | 3 | 2021 | 8066 | 0.040 |
Why?
|
Spondylarthropathies | 1 | 2020 | 14 | 0.040 |
Why?
|
Phosphatidylethanolamines | 1 | 2020 | 130 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 630 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 2024 | 505 | 0.040 |
Why?
|
Caprylates | 1 | 2020 | 113 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2023 | 537 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 4349 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36567 | 0.040 |
Why?
|
Carnitine | 1 | 2020 | 253 | 0.040 |
Why?
|
Azetidines | 1 | 2020 | 151 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2024 | 734 | 0.040 |
Why?
|
Nuts | 1 | 2021 | 265 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.040 |
Why?
|
Translations | 1 | 2019 | 84 | 0.040 |
Why?
|
Blood Urea Nitrogen | 1 | 2018 | 189 | 0.040 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 98 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 723 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 536 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5874 | 0.040 |
Why?
|
Tryptophan | 1 | 2020 | 484 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 975 | 0.040 |
Why?
|
Mass Screening | 2 | 2024 | 5454 | 0.040 |
Why?
|
Methionine | 1 | 2020 | 569 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 4747 | 0.040 |
Why?
|
Diet Records | 1 | 2019 | 425 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20144 | 0.040 |
Why?
|
Transaminases | 1 | 2018 | 198 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 551 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11513 | 0.040 |
Why?
|
Interleukins | 1 | 2022 | 795 | 0.040 |
Why?
|
Telomere | 1 | 2024 | 943 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8891 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2023 | 26389 | 0.040 |
Why?
|
Purines | 1 | 2020 | 615 | 0.030 |
Why?
|
Self Report | 2 | 2022 | 3771 | 0.030 |
Why?
|
DNA | 2 | 2021 | 7208 | 0.030 |
Why?
|
Phosphofructokinase-2 | 1 | 2016 | 33 | 0.030 |
Why?
|
Beer | 1 | 2017 | 135 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2018 | 319 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 576 | 0.030 |
Why?
|
Waist Circumference | 1 | 2020 | 934 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1972 | 0.030 |
Why?
|
Wine | 1 | 2017 | 172 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1802 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6287 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 668 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2021 | 1182 | 0.030 |
Why?
|
Piperidines | 1 | 2024 | 1663 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1555 | 0.030 |
Why?
|
Vasculitis | 1 | 2020 | 528 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1838 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2108 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2493 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2019 | 636 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 30237 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1659 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14652 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4570 | 0.030 |
Why?
|
Placebo Effect | 1 | 2018 | 515 | 0.030 |
Why?
|
Menarche | 1 | 2017 | 532 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 746 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1885 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2015 | 330 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3620 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2921 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2846 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1917 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2018 | 1026 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3043 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3692 | 0.020 |
Why?
|
Medical Informatics | 1 | 2019 | 744 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1297 | 0.020 |
Why?
|
Fear | 1 | 2020 | 1496 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3385 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3208 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7241 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2006 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1814 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1982 | 0.020 |
Why?
|
Genomics | 2 | 2020 | 5923 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2018 | 1072 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1512 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2030 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 790 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1895 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1336 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2971 | 0.020 |
Why?
|
Crohn Disease | 1 | 2022 | 2286 | 0.020 |
Why?
|
Haplotypes | 1 | 2015 | 2727 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12791 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3227 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9357 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 3138 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2142 | 0.020 |
Why?
|
Animals | 3 | 2024 | 168930 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2022 | 18984 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 13036 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3450 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81889 | 0.010 |
Why?
|
Curriculum | 1 | 2018 | 3783 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14471 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8533 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6820 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22352 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 30213 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36461 | 0.010 |
Why?
|
Stroke | 1 | 2018 | 9741 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12245 | 0.010 |
Why?
|